Share ownership Healwell AI Inc.

AIDX

CA42249X1006

Advanced Medical Equipment & Technology

Market Closed - Toronto S.E. Other stock markets 15:59:59 2026-04-15 EDT			5-day change	1st Jan Change
0.8800 ^CAD	+6.02%		+7.32%	+4.76%

03-20	Healwell AI Inc., Q4 2025 Earnings Call, Mar 20, 2026
03-19	HEALWELL AI Brief: Reported an IFRS Net Loss From Continuing Ops of $39.1M in FY25, Vs Net Loss of $24M In FY24	MT

Share class: Healwell AI Inc.

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	30,800,000	0	0	54.36 %
Stock B	1	168,829,039	108,518,751 ( 64.28 %)	0

Major shareholders: Healwell AI Inc.

Name	Equities	%	Valuation
WELL HEALTH TECHNOLOGIES CORP. 33.06 %	97,223,161	33.06 %	53 M $
Ian McCrae 12.12 %	35,643,478	12.12 %	20 M $
Samuel Englebardt 3.911 %	11,504,100	3.911 %	6 M $
George Christodoulou 0.7205 %	2,119,022	0.7205 %	1 M $
Alexander Dobranowski 0.6865 %	2,019,184	0.6865 %	1 M $
Impactreneur Capital Corp. 0.5037 %	1,481,544	0.5037 %	811 886 $
Bradley James Porter 0.0669 %	196,629	0.0669 %	107 753 $
Blake Corbet 0.0542 %	159,375	0.0542 %	87 338 $
Anthony Lam 0.0374 %	110,000	0.0374 %	60 280 $
John Kim 0.0119 %	35,000	0.0119 %	19 180 $
░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░

Name	Equities	%	Valuation
WELL HEALTH TECHNOLOGIES CORP. 85.56 %	30,800,000	85.56 %	17 M $

Breakdown by shareholder type

WELL Health Technologies Corp.	43.53%
Individuals	17.62%
Other	0.5%
Unknown	38.35%

Based on 1000 largest holdings

Geographical origin of shareholders

Canada	44.03%
Individuals	17.62%

Based on 1000 largest holdings

Healwell Al Inc. is a Canada-based healthcare artificial intelligence (AI) company focused on preventative care. The Company, using its own proprietary technology, is developing and commercializing advanced clinical decision support systems that can help healthcare providers detect rare and chronic diseases. The Company's segments include Clinical Research and Patient services, AI and Data sciences and Healthcare Software. The Clinical Research and Patient Services segment includes clinical research contracts and medical consultations provided through the Company's MCI Polyclinic Group Inc. and BioPharma subsidiaries in Ontario. The AI and Data Sciences segment includes integration of advanced AI and data science technologies in healthcare through its Khure Health Inc. and Pentavere divisions. The Company's AutoScribe platform is an advanced AI-powered ambient scribe solution. The Healthcare Software segment includes Intrahealth and Versource healthcare software-as-a-service.

Employees

570

Sector

Advanced Medical Equipment & Technology

More about the company